XML 37 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Balance Sheet Details
6 Months Ended
Jun. 30, 2014
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Balance Sheet Details

2. Balance Sheet Details

Marketable Securities

The Company’s portfolio of available-for-sale securities by contractual maturity consists of the following (in thousands):

 

June 30, 2014

   Maturity
in Years
     Amortized
Cost
     Gross
Unrealized
Gains
     Gross
Unrealized
Losses
     Estimated
Fair

Value
 

Available-for-sale:

              

Government agency securities

     1 or less       $ 1,150       $ 0       $ 0       $ 1,150   

Municipal bonds

     1 or less         975         1         0         976   

Certificates of deposit

     1 or less         3,220         0         0         3,220   

Corporate debentures / bonds

     1 or less         8,152         5         0         8,157   
     

 

 

    

 

 

    

 

 

    

 

 

 

Total short-term marketable securities

        13,497         6         0         13,503   
     

 

 

    

 

 

    

 

 

    

 

 

 
      $ 13,497       $ 6       $ 0       $ 13,503   
     

 

 

    

 

 

    

 

 

    

 

 

 

December 31, 2013

   Maturity
in Years
     Amortized
Cost
     Gross
Unrealized
Gains
     Gross
Unrealized
Losses
     Estimated
Fair

Value
 

Available-for-sale:

              

Government agency securities

     1 or less       $ 2,350       $ 1       $ 0       $ 2,351   

Municipal bonds

     1 or less         2,828         1         0         2,829   

Certificates of deposit

     1 or less         3,360         0         0         3,360   

Corporate debentures / bonds

     1 or less         10,635         3         0         10,638   
     

 

 

    

 

 

    

 

 

    

 

 

 

Total short-term marketable securities

        19,173         5         0         19,178   
     

 

 

    

 

 

    

 

 

    

 

 

 

Available-for-sale:

              

Certificates of deposit

     1 to 2         1,300         0         0         1,300   

Corporate debentures / bonds

     1 to 2         2,143         0         0         2,143   
     

 

 

    

 

 

    

 

 

    

 

 

 

Total long-term marketable securities

        3,443         0         0         3,443   
     

 

 

    

 

 

    

 

 

    

 

 

 
      $ 22,616       $ 5       $ 0       $ 22,621   
     

 

 

    

 

 

    

 

 

    

 

 

 

The Company’s available-for-sale securities are carried on the condensed consolidated balance sheet at fair market value with the related unrealized gains and losses included in accumulated other comprehensive income (loss) on the condensed consolidated balance sheet, which is a separate component of stockholders’ equity. Realized gains and losses on the sale of available-for-sale marketable securities are determined using the specific-identification method.

The Company has a credit facility with one of its banks to allow margin borrowings based on and collateralized by the Company’s investments in cash equivalents and marketable securities held by that bank. Borrowings under the facility incur an interest rate at the bank’s base rate plus 1%. At June 30, 2014, the Company had approximately $2.6 million in cash equivalents and marketable securities held at this bank, and the Company’s unused borrowing capacity at June 30, 2014 under the credit facility was $1.9 million. Any monies borrowed and interest incurred are payable on demand, and there is no express expiration date to the credit facility. During the three and six months ended June 30, 2014, the Company did not borrow against the facility, and had no outstanding borrowings under this facility at June 30, 2014. Under the terms of the credit facility, the bank may liquidate any of the Company’s cash equivalents or marketable securities held at any time in order to recoup the outstanding balance of the facility.

As of June 30, 2014, the Company recorded a net unrealized gain of $6,000. The Company’s net unrealized gain is the result of market conditions affecting its fixed-income, debt and equity securities, which are included in accumulated other comprehensive income (loss) in the condensed consolidated balance sheet for the period then ended.

 

Inventories

Inventories consist of the following (in thousands):

 

     June 30,
2014
     December 31,
2013
 

Finished goods

   $ 21,261       $ 20,870   

Raw materials and components

     4,761         6,923   
  

 

 

    

 

 

 
   $ 26,022       $ 27,793   
  

 

 

    

 

 

 

During the six months ended June 30, 2014, the Company recorded inventory write-downs of $3.0 million related to excess and obsolete inventory and reductions to the carrying value of inventories as a result of lower of cost or market valuations.

Accrued Expenses

Accrued expenses consist of the following (in thousands):

 

     June 30,
2014
     December 31,
2013
 

Royalties

   $ 2,655       $ 4,243   

Payroll and related expenses

     3,437         4,828   

Product warranty

     1,580         2,244   

Market development funds and price protection

     2,258         3,059   

Professional fees

     1,656         1,040   

Deferred revenue

     2,411         2,999   

Restructuring

     3,855         610   

Other

     5,234         4,248   
  

 

 

    

 

 

 
   $ 23,086       $ 23,271   
  

 

 

    

 

 

 

Accrued Warranty Obligations

Accrued warranty obligations consist of the following (in thousands):

 

    Three Months Ended
June 30, 2014
    Three Months Ended
June 30, 2013
    Six Months Ended
June 30, 2014
    Six Months Ended
June 30, 2013
 

Warranty liability at beginning of period

  $ 1,367      $ 2,664      $ 2,244      $ 2,329   

Additions charged to operations

    794        1,708        1,199        3,363   

Deductions from/use of liability

    (581     (1,921     (1,863     (3,241
 

 

 

   

 

 

   

 

 

   

 

 

 

Warranty liability at end of period

  $ 1,580      $ 2,451      $ 1,580      $ 2,451   
 

 

 

   

 

 

   

 

 

   

 

 

 

The Company generally provides one to three years of warranty coverage for products following the date of purchase and the Company accrues the estimated cost of warranty coverage as a component of cost of net revenues in the condensed consolidated statements of operations at the time revenue is recognized. The Company accrues warranty costs based on estimates of future warranty-related replacement, repairs or rework of products. In estimating its future warranty obligations, the Company considers various relevant factors, including the historical frequency and volume of claims, and the cost to replace or repair products under warranty.